Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
2.
J Oral Maxillofac Surg ; 78(12): 2296.e1-2296.e7, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32640206

RESUMEN

Rhinophyma, an unsightly and obstructive skin lesion of the nasal area, can be difficult to treat. Numerous modalities have been tried, including medical, excision, and ablation, with various tools and results. In the present report, we have demonstrated the use of the carbon dioxide (CO2) laser on the nose of a 56-year-old man, with excellent cosmetic results even at 59 months after treatment. Discussion of the disease entity and the advantages and disadvantages of the different treatment options are presented. Given the results shown in our patient, we believe that CO2 laser ablation should be a standard treatment of rhinophyma, given its practicality, predictability, and excellent outcomes.


Asunto(s)
Terapia por Láser , Láseres de Gas , Rinofima , Dióxido de Carbono , Humanos , Láseres de Gas/uso terapéutico , Masculino , Persona de Mediana Edad , Nariz , Rinofima/cirugía
4.
Artículo en Inglés | MEDLINE | ID: mdl-29506916

RESUMEN

OBJECTIVE: Our objective was to determine primary open-angle glaucoma (POAG) prevalence among obstructive sleep apnea (OSA) patients because the perioperative environment risks further damaging the optic nerve. STUDY DESIGN: We analyzed a "convenience sample" referred by Sleep Medicine for oral appliances because of continuous positive airway pressure intolerance. We determined the aggregate prevalence of the 3 POAG subtypes-"classic" open-angle glaucoma (COAG), normal-tension glaucoma (NTG), and open-angle glaucoma suspect (OAGS)-among the index population and compared it with that of same hospital's general population. Similarly determined were associations between OSA severity levels (apnea-hypopnea index [AHI]) and POAG subtypes. RESULTS: Among the study sample of 225 patients with OSA (96.4% male; mean age 58.5 ± 12.3 years), 47 (20.9%) had POAG, with a subtype distribution of COAG: 12 (25.5%), NTG: 8 (17.0%), and OAGS: 27 (57.4%). The POAG prevalence rate among medical center's general population was 2.5%, which was significantly less (P < .00001) than among those with comorbid OSA. Severity of the breathing disorder (AHI) failed to identify a significant correlation to any POAG subtype (P > .05). CONCLUSION: The significant prevalence of POAG among OSA sufferers suggests need for preoperative consultations from an ophthalmologist to determine eye health and possibly an anesthesiologist to avoid potential vision loss.


Asunto(s)
Glaucoma de Ángulo Abierto/epidemiología , Apnea Obstructiva del Sueño/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Comorbilidad , Femenino , Humanos , Los Angeles/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia
5.
Dentomaxillofac Radiol ; 46(5): 20160406, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28186844

RESUMEN

OBJECTIVES: Given the enhanced risk of ischaemic stroke resulting from the direct effects of hyperuricaemia on vascular plaque formation seen among older males with gout, we sought to determine the prevalence of calcified carotid artery atheromas (CCAAs) on their panoramic images (PIs). METHODS: Medical record librarians identified all male patients over 45 years, who had a diagnosis of gout and a PI incidentally obtained between 2000 and 2015. The prevalence rate of CCAA on technically appropriate images was determined, as were these patients' atherogenic risk profiles including: age, body mass index, hypertension and dyslipidaemia. Comparisons of atherogenic risk factors were made between this cohort and those without CCAA. RESULTS: Of the 531 patients with gout, 163 patients were adjudicated to be CCAA+ (the panoramic image demonstrates a calcified carotid artery atheroma). Logistic regression analysis demonstrated that a comorbid diagnosis of diabetes mellitus or dyslipidaemia, or advancing age was determinant in differentiating patients who were CCAA+ vs those who were CCAA- (the panoramic image does not demonstrate a calcified carotid artery atheroma). CONCLUSIONS: CCAAs often herald an ischaemic stroke and may be seen on the PIs of patients with gout, especially those with increased age, dyslipidaemia or diabetes. Thus, dentists must be uniquely vigilant in detecting these lesions when evaluating the images of all patients with gout, especially those with additional positive risk factors.


Asunto(s)
Enfermedades de las Arterias Carótidas/diagnóstico por imagen , Gota/complicaciones , Placa Aterosclerótica/diagnóstico por imagen , Anciano , Enfermedades de las Arterias Carótidas/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Placa Aterosclerótica/epidemiología , Prevalencia , Estudios Retrospectivos , Factores de Riesgo , Estados Unidos/epidemiología
9.
J Oral Maxillofac Surg ; 74(11): 2239.e1-2239.e2, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27575862

RESUMEN

The immediate and long-term consequences of blunt orbital trauma leading to a subluxated lens and its subsequent calcification and opacification are reviewed. The accompanying panoramic image documents the process.


Asunto(s)
Catarata/diagnóstico por imagen , Catarata/etiología , Subluxación del Cristalino/complicaciones , Subluxación del Cristalino/diagnóstico por imagen , Radiografía Panorámica , Anciano , Humanos , Masculino
10.
J Oral Maxillofac Surg ; 74(12): 2403-2408, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27376180

RESUMEN

PURPOSE: The risk of developing concomitant medication-related osteonecrosis of the jaw (MRONJ) in patients who have sustained an atypical femoral fracture (AFF) in association with parental administration of a bisphosphonate osteoclastic inhibitor medication for malignant disease is unclear. Published data were searched to determine the prevalence of these concomitant adverse medication events, if any. MATERIALS AND METHODS: A systematic review of published case series in the PubMed database was undertaken to ascertain the prevalence of patients having a concomitant history of AFF and MRONJ. The data were analyzed to provide prevalence rates of these events from the literature. RESULTS: Two case series were identified that delineated the risk (25 and 33%, respectively) of concomitant development of MRONJ and AFF in recipients of parenteral bisphosphonate medication administered for malignant disease. CONCLUSION: The published data suggest that approximately 30% of patients receiving parenteral bisphosphonates and having sustained an AFF could develop comorbid MRONJ.


Asunto(s)
Osteonecrosis de los Maxilares Asociada a Difosfonatos/etiología , Conservadores de la Densidad Ósea/efectos adversos , Neoplasias Óseas/tratamiento farmacológico , Difosfonatos/efectos adversos , Fracturas del Fémur/inducido químicamente , Fracturas Espontáneas/inducido químicamente , Osteonecrosis de los Maxilares Asociada a Difosfonatos/epidemiología , Conservadores de la Densidad Ósea/uso terapéutico , Difosfonatos/uso terapéutico , Fracturas del Fémur/complicaciones , Fracturas Espontáneas/complicaciones , Humanos , Inyecciones Intravenosas , Prevalencia , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA